Cargando…
Prostatic artery embolization in patients with benign prostatic hyperplasia: perfusion cone-beam CT to evaluate planning and treatment response
This proof of concept is to evaluate the utility of perfusion cone-beam computed tomography (CT) in patients undergoing prostatic artery (PA) embolization (PAE) for benign prostatic hyperplasia (BPH) with moderate or severe-grade lower urinary tract symptoms (LUTS). PAE is a novel minimally invasive...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023075/ https://www.ncbi.nlm.nih.gov/pubmed/33245070 http://dx.doi.org/10.23750/abm.v91i10-S.10260 |
_version_ | 1783675056596975616 |
---|---|
author | Pandolfi, Marco Liguori, Alessandro Gurgitano, Martina Arrichiello, Antonio Di Meglio, Letizia Rodà, Giovanni Guadagni, Alice Angileri, Salvatore Alessio Ierardi, Anna Maria Paolucci, Aldo Carrafiello, Gianpaolo |
author_facet | Pandolfi, Marco Liguori, Alessandro Gurgitano, Martina Arrichiello, Antonio Di Meglio, Letizia Rodà, Giovanni Guadagni, Alice Angileri, Salvatore Alessio Ierardi, Anna Maria Paolucci, Aldo Carrafiello, Gianpaolo |
author_sort | Pandolfi, Marco |
collection | PubMed |
description | This proof of concept is to evaluate the utility of perfusion cone-beam computed tomography (CT) in patients undergoing prostatic artery (PA) embolization (PAE) for benign prostatic hyperplasia (BPH) with moderate or severe-grade lower urinary tract symptoms (LUTS). PAE is a novel minimally invasive therapy and is both safe and effective procedure with low risks and high technical successes, making this procedure as the best alternative to surgery. A lot of technical changes would compromise clinical outcomes after procedure, including a variable prostate vascular anatomy, thin PA, and extensive atherosclerotic disease. The purpose of our study is to exploit the advantages of Perfusion Cone Beam Computed Tomography (CBCT) that could impact treatment and help interventional radiologists for treatment planning, diagnosis and for assessing the technical feasibility during PAE, mitigating the risk of nontarget embolization and suggesting clinical outcomes. Qualitative and quantitative clinical pre- and post-treatment values will be compared, to reach the best possible results. (www.actabiomedica.it) |
format | Online Article Text |
id | pubmed-8023075 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Mattioli 1885 |
record_format | MEDLINE/PubMed |
spelling | pubmed-80230752021-04-07 Prostatic artery embolization in patients with benign prostatic hyperplasia: perfusion cone-beam CT to evaluate planning and treatment response Pandolfi, Marco Liguori, Alessandro Gurgitano, Martina Arrichiello, Antonio Di Meglio, Letizia Rodà, Giovanni Guadagni, Alice Angileri, Salvatore Alessio Ierardi, Anna Maria Paolucci, Aldo Carrafiello, Gianpaolo Acta Biomed Original Article This proof of concept is to evaluate the utility of perfusion cone-beam computed tomography (CT) in patients undergoing prostatic artery (PA) embolization (PAE) for benign prostatic hyperplasia (BPH) with moderate or severe-grade lower urinary tract symptoms (LUTS). PAE is a novel minimally invasive therapy and is both safe and effective procedure with low risks and high technical successes, making this procedure as the best alternative to surgery. A lot of technical changes would compromise clinical outcomes after procedure, including a variable prostate vascular anatomy, thin PA, and extensive atherosclerotic disease. The purpose of our study is to exploit the advantages of Perfusion Cone Beam Computed Tomography (CBCT) that could impact treatment and help interventional radiologists for treatment planning, diagnosis and for assessing the technical feasibility during PAE, mitigating the risk of nontarget embolization and suggesting clinical outcomes. Qualitative and quantitative clinical pre- and post-treatment values will be compared, to reach the best possible results. (www.actabiomedica.it) Mattioli 1885 2020 2020-09-23 /pmc/articles/PMC8023075/ /pubmed/33245070 http://dx.doi.org/10.23750/abm.v91i10-S.10260 Text en Copyright: © 2020 ACTA BIO MEDICA SOCIETY OF MEDICINE AND NATURAL SCIENCES OF PARMA http://creativecommons.org/licenses/by-nc-sa/4.0 This work is licensed under a Creative Commons Attribution 4.0 International License |
spellingShingle | Original Article Pandolfi, Marco Liguori, Alessandro Gurgitano, Martina Arrichiello, Antonio Di Meglio, Letizia Rodà, Giovanni Guadagni, Alice Angileri, Salvatore Alessio Ierardi, Anna Maria Paolucci, Aldo Carrafiello, Gianpaolo Prostatic artery embolization in patients with benign prostatic hyperplasia: perfusion cone-beam CT to evaluate planning and treatment response |
title | Prostatic artery embolization in patients with benign prostatic hyperplasia: perfusion cone-beam CT to evaluate planning and treatment response |
title_full | Prostatic artery embolization in patients with benign prostatic hyperplasia: perfusion cone-beam CT to evaluate planning and treatment response |
title_fullStr | Prostatic artery embolization in patients with benign prostatic hyperplasia: perfusion cone-beam CT to evaluate planning and treatment response |
title_full_unstemmed | Prostatic artery embolization in patients with benign prostatic hyperplasia: perfusion cone-beam CT to evaluate planning and treatment response |
title_short | Prostatic artery embolization in patients with benign prostatic hyperplasia: perfusion cone-beam CT to evaluate planning and treatment response |
title_sort | prostatic artery embolization in patients with benign prostatic hyperplasia: perfusion cone-beam ct to evaluate planning and treatment response |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023075/ https://www.ncbi.nlm.nih.gov/pubmed/33245070 http://dx.doi.org/10.23750/abm.v91i10-S.10260 |
work_keys_str_mv | AT pandolfimarco prostaticarteryembolizationinpatientswithbenignprostatichyperplasiaperfusionconebeamcttoevaluateplanningandtreatmentresponse AT liguorialessandro prostaticarteryembolizationinpatientswithbenignprostatichyperplasiaperfusionconebeamcttoevaluateplanningandtreatmentresponse AT gurgitanomartina prostaticarteryembolizationinpatientswithbenignprostatichyperplasiaperfusionconebeamcttoevaluateplanningandtreatmentresponse AT arrichielloantonio prostaticarteryembolizationinpatientswithbenignprostatichyperplasiaperfusionconebeamcttoevaluateplanningandtreatmentresponse AT dimeglioletizia prostaticarteryembolizationinpatientswithbenignprostatichyperplasiaperfusionconebeamcttoevaluateplanningandtreatmentresponse AT rodagiovanni prostaticarteryembolizationinpatientswithbenignprostatichyperplasiaperfusionconebeamcttoevaluateplanningandtreatmentresponse AT guadagnialice prostaticarteryembolizationinpatientswithbenignprostatichyperplasiaperfusionconebeamcttoevaluateplanningandtreatmentresponse AT angilerisalvatorealessio prostaticarteryembolizationinpatientswithbenignprostatichyperplasiaperfusionconebeamcttoevaluateplanningandtreatmentresponse AT ierardiannamaria prostaticarteryembolizationinpatientswithbenignprostatichyperplasiaperfusionconebeamcttoevaluateplanningandtreatmentresponse AT paoluccialdo prostaticarteryembolizationinpatientswithbenignprostatichyperplasiaperfusionconebeamcttoevaluateplanningandtreatmentresponse AT carrafiellogianpaolo prostaticarteryembolizationinpatientswithbenignprostatichyperplasiaperfusionconebeamcttoevaluateplanningandtreatmentresponse |